Study of Pyridostigmine With Ondansetron in Subjects With Anti-AchR Positive Myasthenia Gravis
Clinical trial NCT04226170 · TERMINATED
Trial details
- NCT number
- NCT04226170
- Sponsor
- DAS-MG, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-08
- Primary completion
- 2025-04-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.